Clinical Trial Update: Lenalidomide and Dexamethasone for Rosai-Dorfman Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating lenalidomide and dexamethasone for Rosai-Dorfman Disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rosai-dorfman Disease

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Lenalidomide (lenalidomide)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Rosai-Dorfman Disease | Phase 2 | Status: UNKNOWN